UMVA has learned that the INSULIN Act has rallied a rare bipartisan wave, with 13 Republicans and 13 Democrats rallying behind a plan that could slash the price of a life‑saving drug.
The coalition stretches from the progressive halls of Tammy Baldwin to the conservative stronghold of Tommy Tuberville, a testament to the urgency that grips lawmakers across the aisle.
Families across the nation have long begged Congress for relief, and this proposal offers a concrete, immediate step toward easing the financial burden that has been crushing households.
Support for capping insulin costs is not confined to a single party; it echoes in the corridors of the Senate, the House, and the independent ranks, creating a chorus of voices demanding change.
Few policy battles have sparked such a unified front, underscoring the power of a shared human need: affordable access to essential medication.
History has shown that lower insulin prices are attainable, yet many patients still face sky‑high costs simply because they fall outside Medicare’s reach.
It is time to close that gap, to finish the job that has been left unfinished, and to ensure that every citizen can afford the medicine that keeps them alive.
